Home Research Reports Advancements in Technology to hold the hopes high for the oncology and “bowel-related” Ailments

Advancements in Technology to hold the hopes high for the oncology and “bowel-related” Ailments

by gbaf mag
28 views
Advancements in Technology to hold the hopes high for the oncology and “bowel-related” Ailments

IV tubing sets and accessories are in great demand due to growing incidences of cancer, followed by several toddlers in the developing countries at the risk of malnutrition. The second reason is bound to dominate in the years to come with the UNICEF stating that improper nutrition in the first 1000 days of the life of an infant are likely to result in impaired cognitive ability and stunted growth. Parenteral nutrition is one of the ways out herein. Product-wise, IV tubing sets and accessories comprise primary IV tubing sets, extension IV tubing sets, secondary IV tubing sets, IV tubing accessories, and likewise. Application-wise, it’s central venous catheter placement, peripheral intravenous catheter insertion, and PICC line insertion.

Digital PCR does make way for high-throughput absolute quantitative analysis regarding presence of RNA or DNA in a sample. Rising number of genetic disorders, cancer, and infectious diseases are driving the digital PCR market. Type-wise, the digital PCR market spans chip-based, droplet, and others. Product-wise, it’s reagents, instruments, and consumables. Coming to developments, Sysmex, in July 2019, did come up with OncoBEAM test that makes use of BEAMing enhanced digital PCR to conduct liquid biopsy.

Surgical hemostats internal tissue sealants and adhesion barriers market, as the name suggests, spans hemostats, internal tissue sealants, and adhesion barriers. By application, it’s trauma cases and surgical applications. The rise in aging population, along with the ever-increasing demand for orthopaedic, cardiovascular treatments is the major factor driving the surgical hemostats internal tissue sealants and adhesion barriers market.

HPL (Human Platelet Lysate) products do contain platelet-derived growth factors as well as cytokines in abundance, which help in stimulating cellular proliferation for maintaining differential potential. Also, it acts as a good alternative to FBL (Fetal Bovine Serum) in tissue and cell culture. ON the expansion front, there is collaboration between Biogelx and PL BioScience GmbH in place. Type-wise, the HPL market spans heparin-free human platelet lysate, and others (fibrogen depleted). Application-wise, it’s therapeutic and research.

Adhesion barrier market is being pushed by the growing aging population along with surgical procedures growing at an alarming rate. At the same time, there are restraints in the form of risk related to post-surgical adhesion. Also, the developing countries are witnessing lack of awareness herein. Product-wise, adhesion barrier market constitutes synthetic adhesion barriers (polyethylene glycol, regenerated cellulose, hyaluronic acid, and others) and natural adhesion barriers (fibrin and collagen & protein). Formulation-wise, it’s gel, liquid, and mesh/film. Application-wise, gynaecological surgeries, abdominal general surgeries, orthopaedic surgeries, cardiovascular surgeries, urological surgeries, neurological surgeries, and many others.

Immune repertoire sequencing market is catalysed by several advancements in NGS (next-generation sequencing). On the developments’ front, ArcherDX Inc. merged with Ambry Genetics for delivering immune repertoire sequencing services. Also, MIODx has collaborated with DiaCarta for developing MIODx’s ClonoMapto in prediction of the patient’s response towards immunotherapy.

Lateral flow assays, better known as “lateral flow immunochromatographic assays”, come across as devices used for detecting absence/presence of target analyte in the sample. Point-of-care testing has been asked for of late. This factor is enough to drive the lateral flow assay market. Product-wise, it’s lateral flow readers (digital/mobile readers and benchtop readers) and kits & reagents. Technique-wise, it’s sandwich assay, competitive assay, and multiplex detection assay. By application, it’s veterinary diagnostics and clinical/point-of-care testing (infectious disease testing, cardiac marker testing, pregnancy & fertility testing, cholesterol & lipid testing, drugs-of-abuse testing, and others), and drug development & quality testing.

Pyrogen testing is in great demand from biotechnology and pharmaceutical industry. By test, it’s oncology monocyte activation test, rabbit pyrogen test, limulus amebocyte lysate, recombinant factor C assay, and in-vitro pyrogen test. Product-wise, it’s consumables and instruments. End-user-wise, it’s medical devices companies, food & beverage companies, pharmaceutical companies, biotechnology companies, CROs (Contract Research Organizations), and others.

Effervescent products are being asked for due to effervescent dietary products and supplements being asked for, along with an increasing utilization of various functional foods. Based on product-type, the effervescent products are categorized as powders, tablets, and granules. On the basis of type, they are pharmaceuticals, probiotics, dental products, electrolytes and energy boosting supplements, vitamins and dietary supplements.

Disposable incontinence products are witnessing an exponential demand due to increasing incidences of chronic diseases like kidney diseases, bladder cancer, endocrine and urological disorders. By products, they are protective incontinence garments (disposable adult diaper, cloth adult diaper, disposable protective underwear, disposable liners and pads (male guards, bladder control pads, and incontinence liners (belted and beltless under garments and disposable under pads)), urine bag (leg urine bag and bedside urine bag), and urinary catheter (indwelling (Foley) catheter, intermittent catheter, and external catheter). Application-wise, urine incontinence, fecal incontinence, and dual incontinence. The type of incontinence could be urge, stressed, mixed, and others. By type of disease, it could be hysterectomy, menopause, childbirth and pregnancy, bladder cancer, mental disorders, benign prostatic hyperplasia.

Persistence Market Research (PMR) has profiled the key players as follows:

  • Unicharm Corporation
  • Kimberly Clark
  • Herbalife Internationaal of America
  • Bayer AG
  • Amerilab Technologies Inc.
  • Associates of Cape Cod
  • Charles River
  • Abbott
  • Danaher Corporation
  • Illumina, Inc.
  • Juno Therapeutics
  • Mast Biosurgery, Inc.
  • Baxter International
  • Biological Industries USA
  • Mill Creek Life Sciences
  • Cryolife Inc.
  • Integra Lifesciences Corporation
  • Sysmex Inostics
  • QIAGEN
  • ICU Medical, Inc.

In all, PMR has assimilated the insights regarding chronic disorders and those related to irritable bowels in its market study.

You may also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More